logo
episode-header-image
Sep 2021
29m 54s

What Causes Alzheimer's?

Science History Institute
About this episode
tail spinning
Up next
Sep 2025
Flemmie Kittrell and the Preschool Experiment
Alexis Pedrick joins Katie Hafner to bring you an episode from The Lost Women of Science Initiative, a non-profit educational organization dedicated to telling the forgotten or untold stories of remarkable female scientists and their groundbreaking work through history. The episo ... Show More
52m 4s
Sep 2025
The CRISPR Babies
In 2018 news broke that a Chinese scientist, He Jiankui, had used CRISPR to edit human embryos, and twin girls had been born as a result. The story set off an explosive bioethical controversy. As gene editing expert Kiran Musunuru put it, "He Jiankui's genetic misadventures were ... Show More
53m 33s
Sep 2025
Humans and Monsters: An Interview with Surekha Davies
The fears about genetic engineering were stoked when experiments took off in the 1970s. From lab leaks to disease epidemics to the ability to make "Frankenstein creations," many of those fears are still with us today. We talk to author Surekha Davies about her latest book, why sh ... Show More
31m 38s
Recommended Episodes
Aug 2023
What difference could new Alzheimer’s disease drugs make?
Until recently, breakthroughs in treating Alzheimer’s disease were non-existent. But two new drugs have shown promise in moderately slowing memory and thinking problems for people with early-stage disease. While welcoming the idea of a ‘new era’ for treating Alzheimer’s disease, ... Show More
28m 37s
Mar 2023
Julie Williams on Alzheimer’s disease
There are almost a million people in the UK living with dementia, and Alzheimer’s is the most common form. But the disease actually starts long before any noticeable symptoms appear, and over the past decade, studies have shown that it is much more complex than previously thought ... Show More
28m 21s
Feb 2022
What you can do to prevent Alzheimer's | Lisa Genova
Alzheimer's doesn't have to be your brain's destiny, says neuroscientist and author of "Still Alice," Lisa Genova. She shares the latest science investigating the disease -- and some promising research on what each of us can do to build an Alzheimer's-resistant brain. TED Talks D ... Show More
21m 41s
Sep 2021
What causes Alzheimer’s?
For decades, Alzheimer’s researchers have been stubbornly pursuing a single theory, but they’re starting to wonder: is this narrow focus the reason we still don’t have a cure? For more, go to http://vox.com/unexplainable It’s a great place to sign up for our newsletter, view show ... Show More
30m 10s
Jun 2023
TWiN 41: Alzheimer's and melanin-concentrating hormone
<p>Vivianne explains how early in Alzheimer's disease, the brain attempts to counteract the increased excitatory drive caused by amyloid deposition, and that melanin-concentrating hormone, produced during sleep, is involved in this protective response.</p> <p>Hosts: <a href= "htt ... Show More
1h 18m
Feb 2021
What you can do to prevent Alzheimer's | Lisa Genova
Alzheimer's doesn't have to be your brain's destiny, says neuroscientist and author of "Still Alice," Lisa Genova. She shares the latest science investigating the disease -- and some promising research on what each of us can do to build an Alzheimer's-resistant brain.Learn more a ... Show More
14m 6s
Sep 2020
Bringing Gamma Back, Again
<p>Today, we return to the lab of neuroscientist Li-Huei Tsai, which brought us one of our favorite stories from four years ago - about the power of flashing lights on an Alzheimer’s-addled (mouse) brain. In this update, Li-Huei tells us about her team’s latest research, which no ... Show More
36m 53s
Jul 2023
How close are we to ending Alzheimer's?
A new drug, Donanemab, has been hailed as a turning point in the fight against Alzheimer's after a global trial confirms it slows cognitive decline.One trial was shown to have “significantly slowed” the progression of the disease—by 35%.Earlier this year, Lecanemab, the first dru ... Show More
48m 39s
Mar 2023
How Well Does A New Alzheimer's Drug Work For Those Most At Risk?
A new drug for Alzheimer's disease, called lecanemab, got a lot of attention earlier this year for getting fast-tracked approval based on a clinical trial that included nearly 1,800 people. It was the most diverse trial for an Alzheimer's treatment to date, but still not enough t ... Show More
13m 46s
Mar 2022
The Science Behind Mental Afflictions
<p>In <a href="https://www.nytimes.com/2022/02/10/books/review/a-molecule-away-from-madness-sara-manning-peskin.html" target="_blank">“A Molecule Away From Madness,”</a> the neurologist Sara Manning Peskin writes about the errant molecular activity that underlies many serious men ... Show More
58m 48s